What HeartcoR Solutions does

HeartcoR Solutions is a US-based cardiac safety core lab founded in 2015 by Larry Lawson (formerly of eCardio/Preventice Solutions) and headquartered in Schaumburg, Illinois. The company delivers expert ECG recording, certified technician analysis, electrophysiologist overreading, and validated data set delivery to pharmaceutical, medical device, and contract research organization (CRO) customers for global regulatory filings and post-market surveillance studies. It is positioned as the top choice for four of the largest global healthcare companies and also serves startups seeking initial market approval.

The core platform supports four ECG collection modes — Event (60-second recordings), Mobile Cardiac Telemetry (MCT, real-time), Holter (24-hour continuous), and 12-lead — and is paired with a growing remote patient monitoring device portfolio including the Wellysis S-Patch EXL (under exclusive partnership), TempTraq, PCA 500, AliveCor, Vivalink Holter Patch, and Mortara 12-lead. HeartcoR sources, deploys, and integrates these devices at global study sites, patient homes, and decentralized healthcare settings across four continents, completing more than 50,000 tracings annually. A May 2026 strategic partnership with Image Analysis Group (IAG) extends the offering into integrated cardiac safety and multimodality imaging core lab services via IAG's DYNAMIKA platform, addressing sponsor demand for unified vendor relationships in regulatory submissions.

HeartcoR generates revenue through professional services tied to clinical trial cardiac safety monitoring (ECG core lab services), sold via enterprise field sales to pharma, medical device, and CRO buyers on a quote-based pricing model. Go-to-market combines direct enterprise sales, conference participation (SCOPE Summit, Heart Rhythm Society, ASCO, OCT series, DPHARM), and content marketing through downloadable capability materials. Leadership has been substantially refreshed in 2024-2025, including the appointment of Ciaran Cooper (formerly of Philips Pharma Solutions) as CEO and the addition of VPs of Client Services, Quality and Compliance, and a CFO, positioning the company for scaled operations following the IAG ecosystem expansion.

Name

HeartcoR Solutions

Legal name

HeartcoR Solutions

Website

https://heartcorsolutions.com

Company type

Private

Founded year

2015

Operating status

Operating

Headcount range

11–50 employees

Short description

HeartcoR Solutions is a US-based ECG core lab that delivers ECG recording, certified technician analysis, electrophysiologist overreading, and validated data sets to pharmaceutical, medical device, and CRO customers for global regulatory filings. It supports four ECG modalities with a multi-device portfolio across four continents.

Ownership category

akta.pro rank

Product category

Cardiac Safety Core Lab Services

NAICS

Other Scientific and Technical Consulting Services (54169)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Imaging & Cardiac Safety Core Labs (ECOG/EEG/ECG) (HLAGAAAJ)

akta.pro secondary industries

Electrophysiology (Heart Rhythm) (HLAKABAC), Cardiology Telemedicine Platforms (HLALAGAB), Hemodynamic Monitoring & Cardiac Diagnostics (Cath Lab, FFR/IVUS/OCT) (HLAHAFAI)

Keywords

• ECG core lab
• Cardiac safety monitoring
• Clinical trial services
• Centralized cardiac monitoring
• Cardiac imaging core lab

Headquarters

HQ city

Algonquin

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales

Revenue model

1. ECG Core Lab Services: HeartcoR provides expert ECG recording, certified technician analysis, electrophysiologist overreading, and validated data set delivery to support pharmaceutical and medical device companies' global regulatory filings for clinical trials.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

HeartcoR Solutions is a global ECG core lab that delivers expert ECG recording, certified technician analysis, board-certified electrophysiologist overreading, and validated data set delivery to support pharmaceutical, medical device, and biotech companies' global regulatory filings for clinical trials. The company sources and deploys advanced ECG recording devices (Event, MCT, Holter, 12-lead modes) at study sites, patient homes, and decentralized healthcare settings, and provides protocol-trained, sponsor-dedicated study teams for ongoing project continuity.

Product overview

HeartcoR Solutions operates as a specialized cardiac safety core lab offering a unified platform of ECG core lab services combined with a portfolio of remote patient monitoring devices. The core services encompass ECG recording, certified technician analysis, electrophysiologist overreading, and validated data delivery across four collection modes (Event, MCT, Holter, 12-lead). The device portfolio includes TempTraq (continuous temperature monitoring), PCA 500 (hospital-quality 12-lead ECG), Wellysis S-Patch EXL (wearable cardiac monitor), AliveCor (event recording), Vivalink Holter Patch (Holter/MCT recording), and Mortara 12-lead system—all integrated into clinical trial workflows to support pharmaceutical, medical device, and biotech companies' regulatory filings.

Differentiator

Problem solved

Functional benefit

Products and services

• ECG Core Lab Services Expert ECG recording, certified technician analysis, board-certified electrophysiologist overreading, and validated data set delivery supporting global regulatory filings for pharmaceutical, medical device, and biotech companies' clinical trials. ECG data is collected across four modes: Event (60-second), Mobile Cardiac Telemetry (MCT, real-time), Holter (24-hour continuous), and 12-lead ECG.
• TempTraq FDA-cleared, Class II medical device that delivers continuous, real-time body temperature monitoring for 72 hours via a one-time-use patch with Bluetooth connectivity, allowing patients to move freely during clinical trials.
• PCA 500 Hospital-quality, 12-lead ECG device from QT Medical that can be easily applied by patients at home or at clinical trial sites. Includes a compact recorder, patented preconnected electrode strips, a mobile app, and a HIPAA-compliant cloud dashboard.
• Wellysis S-Patch EXL FDA-cleared wearable cardiac monitor designed for extended testing periods up to 14 days on a single battery charge. Lightweight (9g), waterproof patch with high arrhythmia detection rate, deployed for HeartcoR clinical trial partners.
• AliveCor ECG technology for 60-second event recordings, allowing clinical study participants to record ECG at any time within a study window. HeartcoR delivers a complete monitoring kit including a smartphone for easy data collection and transmission.
• Vivalink Holter Patch Wireless device for capture, transmission, and storage of Holter and Mobile Cardiac Telemetry (MCT) recordings. Features disposable adhesive, hydrogel for electrical connectivity, a reusable rechargeable design, and shower-resistant construction.
• Mortara AM 12-lead 12-lead wireless recording device that pairs with a Microsoft Surface tablet. A preloaded application ensures easy activation, increased comfort for users, and simplified use for site personnel during clinical trial ECG collection.

Quantifiable outcome

• More than 50,000 tracings completed annually

Named customers1 record

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Four partnerships are on record, tiered core/flagship, key and supporting.

• Image Analysis Group (IAG)core/flagshipStrategic or Co-development Partner · 6 May 2026Strategic partnership announced May 6, 2026 combining HeartcoR's ECG, cardiac monitoring, and endpoint adjudication services with IAG's multimodality imaging core lab expertise and DYNAMIKA technology platform. Creates an end-to-end workflow within a unified operational and data environment, enabling sponsors to reduce vendor fragmentation, access data faster, and strengthen safety narratives for regulatory submissions to global health authorities.
• WellysiskeyTechnology or IntegrationPartnership making the Wellysis S-Patch wearable ECG device available to HeartcoR's clinical trial partners. The FDA-cleared ExL model S-Patch is designed for extended testing periods up to 14 days, is lightweight (9g), waterproof, and minimizes noise while accurately collecting ECG waveforms.
• Blue Spark Technologies, Inc.supportingTechnology or IntegrationAdded TempTraq device from Blue Spark Technologies, Inc. to HeartcoR's suite of remote patient monitoring devices. TempTraq is an FDA-cleared, Class II medical device for continuous, real-time body temperature monitoring with 72-hour operating life.
• QT MedicalsupportingTechnology or IntegrationPartnership for PCA 500 device from QT Medical - a hospital-quality, 12-lead ECG device that can be easily applied by patients at home or at clinical trial sites. Includes patented preconnected electrode strips and HIPAA-compliant cloud dashboard.

Scale indicators3 records

Recent moves6 records

Expansion highlights6 records

Broad incumbents

• ICON plc: ICON is a global full-service CRO that offers cardiac safety and imaging core lab services alongside broader clinical operations. It competes with HeartcoR for sponsor cardiac safety work and is a common career path for HeartcoR's leadership alumni.
• IQVIA: IQVIA is the largest global CRO with broad cardiac safety and centralized diagnostic capabilities. As a broad incumbent, it competes with HeartcoR for large pharma cardiac safety contracts and can bundle ECG services into full-service offerings.
• Laboratory Corporation of America (Covance): LabCorp's Covance segment provides central laboratory and cardiac safety services for clinical trials. It is a broad incumbent that overlaps with HeartcoR's ECG core lab offering for pharmaceutical sponsors.

Direct peers

• Philips BioTel Research (Philips Pharma Solutions): Philips' former BioTel Research business is a historical ECG and cardiac safety core lab serving pharma and device trials. It is a direct peer to HeartcoR, and several HeartcoR senior leaders (including the CEO and VP of Quality) previously held roles there.
• Medifacts International: Medifacts is an ECG and cardiac safety core lab focused on centralized cardiac monitoring for clinical trials. It competes directly with HeartcoR on ECG core lab services for global pharma programs.
• BioTelemetry (Philips): BioTelemetry, now part of Philips, was one of the largest US cardiac monitoring companies and historically competed with HeartcoR's predecessor eCardio/Preventice. It remains a relevant peer in remote cardiac monitoring for clinical trials.
• Clario (Bioclinica + ERT): Formed from the merger of Bioclinica and ERT, Clario is the largest dedicated cardiac safety and clinical endpoint core lab globally. It directly competes with HeartcoR on ECG core lab services for pharma and device trials and is the most relevant scale competitor.
• WorldCare Clinical (Voiant): Voiant (formerly WorldCare Clinical) is a clinical and imaging core lab that provides cardiac safety and imaging services. HeartcoR's VP of Client Services previously led operations there, indicating direct overlap and competitive positioning.
• Biomedical Systems: Biomedical Systems is a specialized cardiac safety and clinical trial core lab offering ECG, Holter, and imaging services to pharma and device sponsors. It is a direct specialist peer to HeartcoR in the ECG core lab niche.

Emerging players

• AliveCor: AliveCor is an FDA-cleared consumer and clinical ECG device maker whose KardiaMobile is also integrated into HeartcoR's device portfolio. It represents an emerging adjacent player that could evolve into a deeper core lab competitor or remain a partner.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/HeartcoRNews

Revenue estimate

Valuation estimate

Number of profiles

Profiles10 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about HeartcoR Solutions